Avricore Health Inc grants stock options for common shares, focusing on advancing pharmacy practice.

From GlobeNewswire: 2025-06-14 01:05:00

Avricore Health Inc. (TSXV: AVCR) has granted stock options for a total of 4,100,000 common shares to directors, officers, employees, and consultants at an exercise price of CAD $0.05 per share. These options vest quarterly and expire 5 years from the grant date. The company’s flagship offering, HealthTab™, is a point-of-care testing solution that provides lab-accurate results in real-time with just a few drops of blood. It offers testing for up to 23 key biomarkers and has added capabilities for bacterial and viral tests, including COVID-19. Avricore Health is focused on advancing pharmacy practice and patient care through innovative technologies.



Read more at GlobeNewswire: Avricore Grants Options